Tango Therapeutics Announces Pricing of $600 Million Upsized Public Offering
Tango Therapeutics priced an upsized public offering of 18.17 million shares and 1.83 million pre-funded warrants at $30.00 per share. The deal generates approximately $600 million in gross proceeds, with J.P. Morgan, Leerink Partners, Cantor, and Stifel acting as joint bookrunners.
Key figures
- Deal Value Usd
- 600000000
- Offering Price
- 30
- Shares Offered
- 18166667
- Pre funded warrants
- 1833395
- Warrant exercise price
- 0.001
- Underwriter option shares
- 3000009
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.